What the studies show
Baar and colleagues report selective clearance of senescent cells and functional restoration in fast-ageing and naturally aged mice, and protection against chemotherapy toxicity.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1
In context
FOXO4-DRI is a cell-penetrating peptide designed to pry the protein FOXO4 away from p53 inside senescent cells, causing those cells to die. In a 2017 Cell paper it restored fitness, fur density and kidney function in aged and prematurely ageing mice. That is the entire evidence base: no human trial, no human safety data, and no regulatory filing. Products sold under the name are unlicensed research chemicals.
FOXO4-DRI is not approved (preclinical). Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is FOXO4-DRI proven to help with fitness, fur density and renal function?
What studies are behind the grade?
Is FOXO4-DRI approved for this?
Other outcomes for FOXO4-DRI
Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →